IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,000 | +14.3% | 186 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | 0.0% | 186 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | – | 186 | +1228.6% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 14 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 14 | +7.7% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 13 | -58.1% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 31 | -49.2% | 0.00% | – |
Q2 2020 | $4,000 | +100.0% | 61 | +45.2% | 0.00% | – |
Q1 2020 | $2,000 | -99.1% | 42 | -98.8% | 0.00% | -100.0% |
Q4 2019 | $219,000 | +7200.0% | 3,616 | +6596.3% | 0.01% | – |
Q3 2019 | $3,000 | +50.0% | 54 | +100.0% | 0.00% | – |
Q2 2019 | $2,000 | -98.9% | 27 | -98.8% | 0.00% | -100.0% |
Q1 2019 | $184,000 | -96.1% | 2,256 | +1914.3% | 0.02% | – |
Q2 2018 | $4,667,000 | +29068.8% | 112 | -63.8% | 0.00% | -100.0% |
Q4 2017 | $16,000 | +700.0% | 309 | +602.3% | 0.00% | – |
Q3 2017 | $2,000 | -87.5% | 44 | -89.3% | 0.00% | -100.0% |
Q1 2017 | $16,000 | -80.7% | 410 | -76.5% | 0.00% | -87.5% |
Q4 2016 | $83,000 | – | 1,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |